SAMI N MALEK, MD
Osteopathic Medicine in Ann Arbor, MI
License number
Michigan 4301084595
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Michigan 4301084595
Category
Osteopathic Medicine
Type
Hematology
License number
Michigan 4301084595
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
1500 Floor Cancer Ctr, Ann Arbor, MI 48109
Phone
(734) 936-6000
(734) 936-2047
(734) 936-2047
Professional information
Dr. Sami N Malek, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Hematology, Medical Oncology, Oncology
Address:
Univers Of Mich Comp Canc Ctr
1500 E Medical Center Dr, Ann Arbor 48109
(734) 647-8901 (Phone)
1500 E Medical Center Dr, Ann Arbor 48109
(734) 647-8901 (Phone)
Certifications:
Hematology, 2005, Internal Medicine, 2001, Medical Oncology, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Univers Of Mich Comp Canc Ctr
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
University of Hamburg / Medical Faculty
Baylor College Of Medicine
Sidney Kimmel Canc Ctr-Johns Hopkins Hosp
University of Hamburg / Medical Faculty
Baylor College Of Medicine
Sidney Kimmel Canc Ctr-Johns Hopkins Hosp
Sami Nimer Malek, Ann Arbor MI
Specialties:
Oncologist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
University of Hamburg, Faculty of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine), American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Sami Nimer Malek, Ann Arbor MI
Specialties:
Internal Medicine, Hematology, Medical Oncology, Hematology & Oncology
Work:
University of Michigan Medical School
1500 E Medical Center Dr, Ann Arbor, MI 48109 Regents of the University of Michigan
1150 W Medical Center Dr, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109 Regents of the University of Michigan
1150 W Medical Center Dr, Ann Arbor, MI 48109
Education:
Universitaet Hamburg (1991)
Biomarkers For Mdm2 Inhibitors For Use In Treating Disease
US Patent:
2011025, Oct 13, 2011
Filed:
Apr 7, 2011
Appl. No.:
13/082163
Inventors:
Shaomeng Wang - Saline MI, US
Sami Malek - Ann Arbor MI, US
Jianting Long - Ann Arbor MI, US
Peter Ouillette - Ypsilanti MI, US
Sami Malek - Ann Arbor MI, US
Jianting Long - Ann Arbor MI, US
Peter Ouillette - Ypsilanti MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
A61K 31/407, A61P 35/02, C12Q 1/02
US Classification:
514409, 435 29
Abstract:
Provided herein are methods for selecting and treating a subject with leukemia, wherein the subject is selected for treatment and is treated with an MDM2 inhibitor because said subject's cells contain an FLT3-ITD mutation.
Uses Of Hypoxia-Inducible Factor Inhibitors
US Patent:
2012026, Oct 18, 2012
Filed:
Jun 25, 2010
Appl. No.:
13/513659
Inventors:
Yang Liu - Ann Arbor MI, US
Yin Wang - Ann Arbor MI, US
Yan Liu - Ann Arbor MI, US
Sami N. Malek - Ann Arbor MI, US
Pan Zheng - Ann Arbor MI, US
Yin Wang - Ann Arbor MI, US
Yan Liu - Ann Arbor MI, US
Sami N. Malek - Ann Arbor MI, US
Pan Zheng - Ann Arbor MI, US
Assignee:
ONCOIMMUNE INC. - Ann Arbor MI
International Classification:
A61K 38/12, A61P 35/00
US Classification:
514 196, 514 199
Abstract:
The present invention relates to treating a hematologic cancer using a Hypoxia- Inducible Factor (HIF inhibitor). The invention also relates to inducing acute myeloid leukemia remission using the HIF inhibitor. The invention further relates to inhibiting a maintenance or survival function of a cancer stem cell (CSC) using the HIF inhibitor.